Panacea Acquisition
| General Information | |
| Business: |
While we may pursue an initial business combination opportunity in any industry or geographical location, we intend to capitalize on our management team’s background and experience to identify promising opportunities in the biotechnology sector. |
| Industry: | BLANK CHECKS |
| Employees: | 0 |
| Founded: | 2020 |
| Contact Information | |
| Address | 357 Tehama Street, Floor 3, San Francisco, CA 94103, US |
| Phone Number | (415) 966-0807 |
| Web Address | |
| View Prospectus: | Panacea Acquisition |
| Financial Information | |
| Market Cap | $160.75mil |
| Revenues | $0 mil (last 12 months) |
| Net Income | $0 mil (last 12 months) |
| IPO Profile | |
| Symbol | PANA.U |
| Exchange | NYSE |
| Shares (millions): | 12.5 |
| Price range | $10.00 - $10.00 |
| Est. $ Volume | $125.0 mil |
| Manager / Joint Managers | Cowen and Company |
| CO-Managers | - |
| Expected To Trade: | 7/1/2020 |
| Status: | Priced |
| Quiet Period Expiration Date: | Available only to Subscribers |
| Lock-Up Period Expiration Date: | Available only to Subscribers |
| SCOOP Rating | Available only to Subscribers |
| Rating Change | Available only to Subscribers |